Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This prospectively enrolled, pragmatic randomized trial aims to investigate whether very low dose edoxaban regimen (15 mg daily) achieves similar edoxaban concentrations as low dose edoxaban regimen (30 mg daily), while maintaining a comparable risk of clinical outcomes and reducing major bleeding in elderly patients with atrial fibrillation and a history of ischemic stroke or transient ischemic attack.
Epistemonikos ID: 648dfca1925b4625c071a3f9e86fefa19b26b5ab
First added on: Mar 29, 2025